Ginkgo bioworks financial statements
WebDec 31, 2024 · Ginkgo Bioworks Reports Fourth Quarter and Full Year 2024 Financial Results. DNA March 1, 2024. $478 million of total revenue in 2024, representing an increase of 52% over 2024 and toward the high end of guidance. 59 new Cell Programs added in 2024, representing 90% growth over 2024 and toward the high end of guidance. WebMar 1, 2024 · Ginkgo Bioworks Reports Fourth Quarter and Full Year 2024 Financial Results. $478 million of total revenue in 2024, representing an increase of 52% over 2024 and toward the high end of guidance ...
Ginkgo bioworks financial statements
Did you know?
Web1 day ago · Ginkgo Bioworks is the leading horizontal platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and ... WebMay 16, 2024 · Forward-Looking Statements of Ginkgo Bioworks This press release, the presentation, and the conference call and webcast contain certain forward-looking statements within the meaning of the federal securities laws, including statements regarding our plans, strategies, current expectations, operations and anticipated results …
WebApr 8, 2024 · Ginkgo Bioworks Holdings, Inc. (NYSE:DNA - Get Rating) insider Reshma P. Shetty sold 37,650 shares of the stock in a transaction on Wednesday, April 5th. The stock was sold at an average price of $1.22, for a total value of $45,933.00. Following the transaction, the insider now owns 13,767,604 shares of the company's stock, valued at … WebMar 1, 2024 · Ginkgo Bioworks Reports Fourth Quarter and Full Year 2024 Financial Results. $478 million of total revenue in 2024, representing an increase of 52% over 2024 and toward the high end of guidance ...
WebApr 14, 2024 · Ginkgo Bioworks is the leading horizontal platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across … WebJun 30, 2024 · Provides Ginkgo Bioworks(DNA)financial reports, including historical and latest financial statement data and analysis. You can query by quarterly, interim, and annual reports, and compare historical data easily.
Web3 hours ago · About Ginkgo Bioworks. Ginkgo Bioworks is the leading horizontal platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse ...
WebNov 14, 2024 · Third quarter 2024 Biosecurity revenue of $42 million, down from $43 million in the comparable prior year period, a decrease of 3%. Third quarter 2024 Biosecurity gross profit margin of 41%. Third quarter 2024 Loss from operations of $ (653) million (inclusive of stock-based compensation expense of $563 million), compared to Loss from ... tp link easymeshWebView DNA financial statements in full, including balance sheets and ratios. ... Ginkgo Bioworks Holdings Inc. DNA (U.S.: NYSE) search. View All companies. AT CLOSE 4:00 … tp link eap245 configurationWebApr 14, 2024 · BOSTON and KINSHASA , Democratic Republic of the Congo , April 14, 2024 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), which is building the leading … tp link easy smart configurationWeb2024. 2024 Proxy Statement. 2024 Letter to Shareholders. 2024 Annual Report. tplink emulationWebTen years of annual and quarterly financial statements and annual report data for Ginkgo Bioworks Holdings (DNA). Income statements, balance sheets, cash flow statements … thermosfles tefalWebApr 14, 2024 · BOSTON and KINSHASA, Democratic Republic of the Congo, April 14, 2024 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), which is building the leading … tp link enable wireless radioWebJan 11, 2024 · Ginkgo reiterated its expectations of 55-60 new Cell Programs added to the Foundry platform in 2024; Ginkgo continues to expect Total revenue of $460 – 480 million in 2024 . Preliminary unaudited Foundry revenue is expected to be below the previously disclosed guidance of $150 – $170 million in 2024 due to a subset of targeted milestones … tplink ec220-f5